Phidea Group is a full service CRO (Contract Research Organization); with headquarters in Milan, existing as Phidea since 1982, providing clinical and regulatory expertise to the pharmaceutical, biotechnology and medical device industries. It is privately held and has a rich history built over more than 30 years. The founder Vincenzo Cocuzza, MD continues at the helm.
Our success during these past 30 years has been built around quality, flexibility, integrity, high levels of customer satisfaction and repeat business. Our experience has shaped our understanding of the many clinical and regulatory challenges facing healthcare providers and todays healthcare industry. Our professional staff and consultants have insight and expertise acquired across a broad range of medical specialties/therapeutic areas.
Through the years Phidea has specialized in clinical development, managing multinational pre-registration clinical trials (Phases I, II, III), post marketing clinical trials (Phase IV), as well as epidemiological studies, observational studies and outcome studies, in both East Europe & West Europe.
These organizational assets - people and processes - are the driving force behind our goal of providing a level of performance that meets professional standards of quality and accuracy for every client, regardless of size or location, whilst always following a path of absolute reliability.